DOCSLIB.ORG

Dr. Duke's Phytochemical and Ethnobotanical Databases List of Chemicals for Tinnitus

Total Page：16

File Type：pdf, Size：1020Kb

Download full-text PDF Read full-text
Dr. Duke's Phytochemical and Ethnobotanical Databases List of Chemicals for Tinnitus Dr. Duke's Phytochemical and Ethnobotanical Databases List of Chemicals for Tinnitus Chemical Activity Count (+)-ALPHA-VINIFERIN 1 (+)-AROMOLINE 1 (+)-BORNYL-ISOVALERATE 1 (+)-CATECHIN 1 (+)-EUDESMA-4(14),7(11)-DIENE-3-ONE 1 (+)-HERNANDEZINE 2 (+)-ISOLARICIRESINOL 1 (+)-NORTRACHELOGENIN 1 (+)-PSEUDOEPHEDRINE 1 (+)-SYRINGARESINOL-DI-O-BETA-D-GLUCOSIDE 1 (+)-T-CADINOL 1 (-)-16,17-DIHYDROXY-16BETA-KAURAN-19-OIC 1 (-)-ALPHA-BISABOLOL 1 (-)-ANABASINE 1 (-)-APOGLAZIOVINE 1 (-)-BETONICINE 1 (-)-BORNYL-CAFFEATE 1 (-)-BORNYL-FERULATE 1 (-)-BORNYL-P-COUMARATE 1 (-)-CANADINE 1 (-)-DICENTRINE 1 (-)-EPICATECHIN 2 (-)-EPIGALLOCATECHIN-GALLATE 1 (1'S)-1'-ACETOXYCHAVICOL-ACETATE 1 (E)-4-(3',4'-DIMETHOXYPHENYL)-BUT-3-EN-OL 1 1,7-BIS-(4-HYDROXYPHENYL)-1,4,6-HEPTATRIEN-3-ONE 1 1,8-CINEOLE 4 Chemical Activity Count 1-ETHYL-BETA-CARBOLINE 2 10-ACETOXY-8-HYDROXY-9-ISOBUTYLOXY-6-METHOXYTHYMOL 1 10-DEHYDROGINGERDIONE 1 10-GINGERDIONE 1 12-(4'-METHOXYPHENYL)-DAURICINE 1 12-METHOXYDIHYDROCOSTULONIDE 1 13',II8-BIAPIGENIN 1 13-HYDROXYLUPANINE 1 13-OXYINGENOL-ESTER 1 16,17-DIHYDROXY-16BETA-KAURAN-19-OIC 1 16-HYDROXY-4,4,10,13-TETRAMETHYL-17-(4-METHYL-PENTYL)-HEXADECAHYDRO- 1 CYCLOPENTA[A]PHENANTHREN-3-ONE 16-HYDROXYINGENOL-ESTER 1 2'-O-GLYCOSYLVITEXIN 1 2-BETA,3BETA-27-TRIHYDROXYOLEAN-12-ENE-23,28-DICARBOXYLIC-ACID 1 2-METHYLBUT-3-ENE-2-OL 2 2-VINYL-4H-1,3-DITHIIN 1 20-DEOXYINGENOL-ESTER 1 22BETA-ESCIN 1 24-METHYLENE-CYCLOARTANOL 2 3,3'-DIMETHYLELLAGIC-ACID 1 3,4-DIMETHOXYTOLUENE 2 3,4-METHYLENE-DIOXYCINNAMIC-ACID-BORNYL-ESTER 1 3,4-SECOTRITERPENE-ACID-20-EPI-KOETJAPIC-ACID 1 3-ACETYLACONITINE 1 3-ACETYLNERBOWDINE 1 3-ALPHA-DIHYDROCADAMBINE 1 3-BETA-HYDROXY-2,3-DIHYDROWITHANOLIDE-F 2 2 Chemical Activity Count 3-N-BUTYL-PHTHALIDE 4 3-O-ACETYLOLEANOLIC-ACID 1 3-OXO-11-ALPHA-HYDROXYOLEAN-12-ENE-30-OIC-ACID 1 3-OXO-11-ALPHA-METHOXYOLEAN-12-ENE-30-OIC-ACID 1 3-OXO-OLEAN-9(11),12-DIENE-30-OIC-ACID 1 4'-O-METHYLCURINE 1 4-VINYL-GUAIACOL 1 5,6-DI-C-GLUCOSYLAPIGENIN 1 5,7-DIMETHOXYFLAVONE 1 5-DEOXYINGENOL-ESTER 1 5-HYDROXYTRYPTAMINE 1 5-HYDROXYTRYPTOPHAN 1 5-METHOXY-N,N-DIMETHYLTRYPTAMINE 1 6,7-DIMETHYLAESCULETIN 1 6,7-DIMETHYLESCULETIN 1 6-DEHYDROGINGERDIONE 1 6-DEOXYJACAREUBIN 1 6-GINGERDIONE 1 6-GINGEROL 2 6-METHOXY-BENZOLINONE 1 6-METHOXYBENZOXAZOLINONE 1 6-O-(2''-ACETYL-3'',4''-O-DI-P-METHOXYCINNAMOYL-ALPHA-L-RHAMNOPYRANOSYL)-CATALPOL 1 6-O-(4''-ACETYL-2'',3''-O-DI-P-METHOXYCINNAMOYL-ALPHA-L-RHAMNOPYRANOSYL)-CATALPOL 1 6-SHOGAOL 3 7-METHOXYCOUMARIN 1 8-ACETYLHARPAGIDE 1 8-O-CINNAMOYLHARPAGIDE 1 3 Chemical Activity Count 9,12,13-TRIHYDROXY-10,11-EPOXY-OCTADECANOIC-ACID 1 9-METHOXYELLIPTICINE 1 9-O-ETHYLLYCORENINE 1 ABRINE 1 ACANTHOIC-ACID 1 ACANTHOIDINE 1 ACANTHOSIDE-D 1 ACETIC-ACID 1 ACETONE 1 ACETYL-11-KETO-BETA-BOSWELLIC-ACID 1 ACETYL-BETA-BOSWELLIC-ACID 1 ACETYL-CHOLINE 2 ACETYLANDROMEDOL 1 ACETYLSALICYLIC-ACID 1 ACETYLSHIKONIN 1 ACHYRANTHINE 1 ACONITINE 2 ACORIC-ACID 2 ACRONYCIDINE 1 ACTEIN 1 ACTINIDOLES 1 ACYLSPINOSIN 1 ADENOSINE 7 ADENOSINE-TRIPHOSPHATE 1 ADIANTIFOLINE 1 AESCIN 1 AESCULETIN 2 4 Chemical Activity Count AESCULIN 1 AFFININE 1 AFFINISINE 1 AGARIC-ACID 1 AJMALICINE 3 AJMALINE 2 AJMALININE 1 AJOENE 2 AKUAMMIDINE 3 AKUAMMINE 1 ALANTOLACTONE 3 ALBANOL-A 1 ALISOL-A 1 ALISOL-A-MONOACETATE 1 ALISOL-B 1 ALISOL-B-MONOACETATE 1 ALKANNIN 1 ALKAVERVIR 1 ALLANTOIN 1 ALLICIN 4 ALLIIN 1 ALLOPURINOL 1 ALPHA-AMYRIN 1 ALPHA-AMYRIN-ACETATE 1 ALPHA-AMYRIN-PALMITATE 1 ALPHA-BISABOLOL 1 ALPHA-BOSWELLIC-ACID 1 5 Chemical Activity Count ALPHA-CURCUMENE 1 ALPHA-LINOLENIC-ACID 3 ALPHA-PEROXYACHIFOLIDE 1 ALPHA-PINENE 2 ALPHA-SPINASTEROL 1 ALPHA-TERPINEOL 2 ALPHA-TOCOPHEROL 1 ALSEROXYLON 1 AMBELLINE 1 AMENTOFLAVONE 1 AMINOPHYLLINE 1 AMMIOL 1 AMYGDALIN 1 AMYL-BUTYRATE 1 AMYLASE 1 ANABASINE 1 ANDROGRAPHOLIDE 1 ANDROMEDOTOXIN 1 ANEMONIN 1 ANETHOLE 1 ANGELIC-ACID 1 ANGELICIN 4 ANGELICOTOXIN 1 ANGIOTENSIN 1 ANISATIN 1 ANISODINE 1 ANKORINE 1 6 Chemical Activity Count ANNOMONTINE 2 ANONAINE 1 ANTHOCYANIDINS 1 ANTHOCYANINS 1 ANTHOCYANOSIDE 2 ANTHRANILIC-ACID 1 APIGENIN 7 APIGENIN-7-GLYCOSIDE 1 APIGENIN-7-O-GLUCOSIDE 1 APIGENIN-DIMETHYL-ETHER 1 APO-BETA-ERYTHROIDINE 1 APO-N-METHYLCROTSPARINE 1 APOCYANIN 1 APOCYNIN 2 APODINE 1 APOGLAZIOVINE 1 APOMORPHINE 2 AR-TURMERONE 1 ARBORINE 1 ARBORININE 1 ARECOLINE 2 ARGININE 1 ARISTOLOCHIC-ACID 1 ARMILLARIEN-A 1 ARTABSIN 1 ARTECANIN 1 ARTEMETIN 1 7 Chemical Activity Count ARVENOSIDE-A 1 ASARONE 3 ASCARIDOLE 1 ASCORBIC-ACID 7 ASIATICOSIDE 1 ASPERULOSIDE 2 ASPIRIN 1 ASPIRIN (ACETYLSALICYLIC-ACID; NOT NATURAL) 1 ASTRAGALIN 1 ASTRAMEMBRANIN-I 2 ASTRASIERVERSIANIN-XVI 1 ASTRINGENIN 1 ATHEROSPERMIDINE 1 ATHEROSPERMINE 1 ATHONIN 1 ATISINE 1 ATRACTYLENOLIDE 1 ATRACTYLENOLIDE-I 1 ATRACTYLENOLIDE-II 1 ATRACTYLENOLIDE-III 1 ATRACTYLOCHROMENE 1 ATRACTYLON 1 ATROPINE 2 AUCUBIN 1 AURASPERONE-D 1 AURICULOSIDE 3 AVISAN 1 8 Chemical Activity Count AXILLARIN 1 AZULENE 1 BACCOSIDES 1 BAICALEIN 3 BAICALEIN-5,6,7-TRIHYDROXY-FLAVONE 1 BAICALIN 4 BALDRINAL 1 BAOHUOSIDE-1 1 BARBATOSIDE-A 1 BARBATOSIDE-B 1 BARTSIOSIDE 1 BASSIC-ACID 1 BAVACHININ 1 BAYACHININE 1 BENZALDEHYDE 1 BENZOIC-ACID 1 BENZOXAZINOIDS 1 BENZOYLACONINE 1 BENZYL-ACETATE 1 BENZYL-ALCOHOL 1 BENZYL-BENZOATE 3 BERBAMINE 3 BERBERASTINE 5 BERBERINE 5 BERGAPTEN 3 BERGENIN 2 BETA-AESCIN 1 9 Chemical Activity Count BETA-AMYRIN 1 BETA-AMYRIN-ACETATE 1 BETA-AMYRIN-PALMITATE 2 BETA-BOSWELLIC-ACID 1 BETA-CAROTENE 1 BETA-DAMASCENONE 1 BETA-ECDYSONE 1 BETA-ERYTHROIDINE 2 BETA-ESCIN 1 BETA-EUDESMOL 2 BETA-HIMACHALINE 1 BETA-IONONE 1 BETA-PHENYLETHANOL 1 BETA-PINENE 1 BETA-RESERCYCLIC-ACID 1 BETA-SANTALENE 1 BETA-SITOSTEROL 2 BETA-SITOSTEROL-3-O-BETA-D-GLUCOPYRANOSIDE 1 BETA-SITOSTEROL-D-GLUCOSIDE 1 BETA-TURMERONE 1 BETONICINE 1 BETULIN 1 BETULINIC-ACID 1 BIOCHANIN-A 1 BIS-(4-HYDROXY-CINNAMOYL)-METHANE 1 BIS-DESMETHOXYCURCUMIN 1 BISABOLOXIDE 1 10 Chemical Activity Count BOEHMEROL-ACETATE 1 BOLDINE 2 BOLDINE-METHOCHLORIDE 2 BORJATRIOL 1 BORNEOL 4 BORNYL-ACETATE 2 BOSWELLIC-ACID 2 BOWDICHIONE 1 BRADYKININASE 1 BRAHMINE 1 BRAHMINOSIDE 2 BRAHMOSIDE 2 BRAZILIN 1 BROMELAIN 3 BROUSSOCHALCONE-A 1 BRYONOLIC-ACID 1 BUFOTENIDINE 1 BUFOTENINE 1 BULBOCAPNINE 3 BUPLEURIN 1 BUTEIN 1 BUTYL-ALCOHOL 1 BUTYL-PHTHALIDE 2 BUTYLIDENE-PHTHALIDE 1 CAFESTOL 1 CAFFEIC-ACID 6 CAFFEINE 1 11 Chemical Activity Count CAFFEOYLMARIC-ACID 1 CAFFEOYLTARTARIC-ACID 1 CAFTARIC-ACID 1 CALCIUM 9 CALLIGONINE 1 CALOPHYLLIN-B 1 CALOPHYLLOLIDE 1 CALPURNINE 1 CAMPESTEROL 1 CANADINE 1 CANBISOL 1 CANESCINE 1 CANNABICHROMENE 1 CANNABIDIOL 1 CANNABIDIOLIC-ACID 1 CANNABIGEROL 1 CANNABINOL 1 CANNFLAVIN 1 CANNIPRENE 1 CAPSAICIN 1 CARACURINE 1 CARANINE 1 CARBENOXOLONE 1 CARBOXYATRACTYLOSIDE 1 CARNITINE 1 CARNOSINE 1 CARNOSOL 1 12 Chemical Activity Count CARPACIN 1 CARPAINE 2 CARPAINE-HCL 1 CARVACROL 2 CARVONE 1 CARYOPHYLLENE 2 CARYOPHYLLENE-OXIDE 1 CASIMIDENE 1 CASIMIROEDINE 1 CATECHIN 2 CATHADINE 1 CEPHARAMINE 1 CEPHARANOLINE 1 CEPHARANTHINE 1 CEVINE 1 CHAKSINE 3 CHAMAZULENE 1 CHAPUZINA 1 CHARCOAL 1 CHEBULIN 1 CHELERYTHRINE 2 CHELIDONINE 4 CHIKUSETSUSAPONIN 2 CHIKUSETSUSAPONIN-V 1 CHLOROGENIC-ACID 3 CHLOROGENIN 1 CHLOROPHYLL 1 13 Chemical Activity Count CHOLINE 1 CHOLINE-SALICYLATE 1 CHROMIUM 3 CHRYSANTHEMOL 1 CHRYSIN 6 CHRYSIN-5,7-DIHYDROXYFLAVONE 1 CHRYSOSPLENIN 1 CHRYSOSPLENOL 1 CHYMOTRYPSIN 1 CICHORIC-ACID 1 CIMIFUGIN 1 CINCHOPHYLLAMINE 2 CINCHOPHYLLINE 3 CINNAMALDEHYDE 4 CINNAMIC-ACID 1 CINNAMIC-ACID-BORNYL-ESTER 1 CINNAMOYLHISTAMINE 1 CIRSILINEOL 1 CIRSIMARITIN 1 CIS-COMMUNIC-ACID 1 CIS-SPIROETHER 2 CISSAMPELINE 1 CISSAMPELOSIN 1 CITRAL 3 CITRIC-ACID 1 CITRONELLAL 1 CITRONELLOL 1 14 Chemical Activity Count CLITORIACETAL 1 CNICIN 1 CNIDILIDE 1 COCAINE 1 COCCULIDINE 1 COCCULINE 1 CODEINE 1 CODONOPSINE 1 COIXENOLIDE 2 COIXOL 1 COLCHICINE 1 COLCHICOSIDE 1 COLEONOL 1 COLFORSIN 1 COLUBRIN 1 COLUBRINOSIDE 1 COLUMBAMINE 2 COLUMBIANADIN 1 CONDELPHINE 1 CONIFERYL-ALDEHYDE 1 CONJUGATED-LINOLEIC-ACID 1 CONOPHARYNGINE 1 CONSOLIDINE 1 COPPER 2 COPPER-SALICYLATE 1 COPTISINE 1 COREXIMINE 1 15 Chemical Activity Count CORILAGIN 1 CORONARIDINE 2 CORYDALINE 1 CORYDINE 2 CORYNANTHEDINE 1 CORYNANTHEINE 2 CORYNANTHINE 1 CORYTUBERINE 1 COUMARIN 2 COUMESTROL 1 CRINAMINE 1 CROCETIN 1 CROTALOBURINE 1 CRYOGENINE 3 CRYPTENAMINE 1 CRYPTOAESCIN 1 CRYPTOCARYALACTONE 2 CRYPTOLEPINE 1 CUACHICHICINE 1 CUCURBITACIN-B 1 CUCURBITOCITRIN 1 CULARINE 2 CUMINALDEHYDE 1 CUPARENE 1 CURCUMIN 4 CURCUMINOIDS 1 CURINE 1 16 Chemical Activity Count CUSSONOSIDE-A 1 CYANIDIN-3-O-GLUCOSIDE 1 CYCLEANINE 3 CYCLOARTENOL 2 CYCLOBUXINE-D 1 CYCLOSADOL 1 CYCLOSTACHINE-A 1 CYMARIN 1 CYNARIN 1 CYNAROSIDE 1 CYTISINE 1 D-LIMONENE 1 DAIDZEIN 2 DAIDZEN 1 DAIDZIN 1 DAIGREMONTIANIN 1 DAIJISON 1 DAIJISONG 1 DAMASCEINE 1 DAPHNOLINE 1 DAURICINE 4 DAURICOLINE 1 DAURINOLINE 1 DAURISOLINE 1 DEHYDRO-BETA-ERYTHROIDINE 1 DEHYDROCURDIONE 1 DEHYDROCYCLOGUANANDIN 1 17 Chemical Activity Count DELCORINE 1 DELCOSINE 1 DELSOLINE 1 DELTA-3-CARENE 1 DELTA-9-THC 1 DELTA-TOCOPHEROL 1 DELTALINE 1 DEMETHOXYCURCUMIN 1 DEMETHYLTETRANDRINE 1 DENDROBINE 1 DEOXYNUPHARIDINE 1 DESERPIDINE 3 DESMETHOXYANGONIN 3 DIABOLINE 2 DIALLYL-DISULFIDE 1 DIALLYL-SULFIDE 1 DIALLYL-TRISULFIDE 1 DIAZEPAM 3 DICAFFEOYLQUINIC-ACID 1 DICENTRINE 1 DICHOTOSIN 2 DICHROIDINE 1 DIDROVALTRATUM 1 DIFFUTIN 3 DIHYDROCAPSAICIN 1 DIHYDROCORYNANTHEINE 2 DIHYDROHELENALIN 1 18 Chemical Activity Count DIHYDROHELENALIN-ESTERS 1 DIHYDROKAWAIN 3 DIHYDROMETHYSTICIN 4 DIHYDROVALTRATE 1 DILLAPIOL 1 DIMETHOXYALLYLBENZENE 1 DIMETHYLROLOBINE-IODIDE 1 DIMETHYLVINYLCARBINOL 1 DIOSGENIN 3 DIOSMIN 1 DIPENTENE 1 DIPHENYL 1 DIPHENYLHYDANTOIN 1 DITETRAHYDROPALMATINE 1 DL-DEMETHYLCOCLAURINE 2 DL-TETRAHYDROPALMATINE 1 DUBINIDINE 2 DYSOBININ 1 ECHITAMINE 2 EDPETILINE 1 EICOSAPENTAENOATE 1 EICOSAPENTAENOIC-ACID
Load more

Recommended publications
  • INVESTIGATION of NATURAL PRODUCT SCAFFOLDS for the DEVELOPMENT of OPIOID RECEPTOR LIGANDS by Katherine M
    INVESTIGATION OF NATURAL PRODUCT SCAFFOLDS FOR THE DEVELOPMENT OF OPIOID RECEPTOR LIGANDS By Katherine M. Prevatt-Smith Submitted to the graduate degree program in Medicinal Chemistry and the Graduate Faculty of the University of Kansas in partial fulfillment of the requirements for the degree of Doctor of Philosophy. _________________________________ Chairperson: Dr. Thomas E. Prisinzano _________________________________ Dr. Brian S. J. Blagg _________________________________ Dr. Michael F. Rafferty _________________________________ Dr. Paul R. Hanson _________________________________ Dr. Susan M. Lunte Date Defended: July 18, 2012 The Dissertation Committee for Katherine M. Prevatt-Smith certifies that this is the approved version of the following dissertation: INVESTIGATION OF NATURAL PRODUCT SCAFFOLDS FOR THE DEVELOPMENT OF OPIOID RECEPTOR LIGANDS _________________________________ Chairperson: Dr. Thomas E. Prisinzano Date approved: July 18, 2012 ii ABSTRACT Kappa opioid (KOP) receptors have been suggested as an alternative target to the mu opioid (MOP) receptor for the treatment of pain because KOP activation is associated with fewer negative side-effects (respiratory depression, constipation, tolerance, and dependence). The KOP receptor has also been implicated in several abuse-related effects in the central nervous system (CNS). KOP ligands have been investigated as pharmacotherapies for drug abuse; KOP agonists have been shown to modulate dopamine concentrations in the CNS as well as attenuate the self-administration of cocaine in a variety of species, and KOP antagonists have potential in the treatment of relapse. One drawback of current opioid ligand investigation is that many compounds are based on the morphine scaffold and thus have similar properties, both positive and negative, to the parent molecule. Thus there is increasing need to discover new chemical scaffolds with opioid receptor activity.
    [Show full text]
  • Opportunities and Pharmacotherapeutic Perspectives
    biomolecules Review Anticoronavirus and Immunomodulatory Phenolic Compounds: Opportunities and Pharmacotherapeutic Perspectives Naiara Naiana Dejani 1 , Hatem A. Elshabrawy 2 , Carlos da Silva Maia Bezerra Filho 3,4 and Damião Pergentino de Sousa 3,4,* 1 Department of Physiology and Pathology, Federal University of Paraíba, João Pessoa 58051-900, Brazil; [email protected] 2 Department of Molecular and Cellular Biology, College of Osteopathic Medicine, Sam Houston State University, Conroe, TX 77304, USA; [email protected] 3 Department of Pharmaceutical Sciences, Federal University of Paraíba, João Pessoa 58051-900, Brazil; [email protected] 4 Postgraduate Program in Bioactive Natural and Synthetic Products, Federal University of Paraíba, João Pessoa 58051-900, Brazil * Correspondence: [email protected]; Tel.: +55-83-3216-7347 Abstract: In 2019, COVID-19 emerged as a severe respiratory disease that is caused by the novel coronavirus, Severe Acute Respiratory Syndrome Coronavirus-2 (SARS-CoV-2). The disease has been associated with high mortality rate, especially in patients with comorbidities such as diabetes, cardiovascular and kidney diseases. This could be attributed to dysregulated immune responses and severe systemic inflammation in COVID-19 patients. The use of effective antiviral drugs against SARS-CoV-2 and modulation of the immune responses could be a potential therapeutic strategy for Citation: Dejani, N.N.; Elshabrawy, COVID-19. Studies have shown that natural phenolic compounds have several pharmacological H.A.; Bezerra Filho, C.d.S.M.; properties, including anticoronavirus and immunomodulatory activities. Therefore, this review de Sousa, D.P. Anticoronavirus and discusses the dual action of these natural products from the perspective of applicability at COVID-19.
    [Show full text]
  • Retention Indices for Frequently Reported Compounds of Plant Essential Oils
    Retention Indices for Frequently Reported Compounds of Plant Essential Oils V. I. Babushok,a) P. J. Linstrom, and I. G. Zenkevichb) National Institute of Standards and Technology, Gaithersburg, Maryland 20899, USA (Received 1 August 2011; accepted 27 September 2011; published online 29 November 2011) Gas chromatographic retention indices were evaluated for 505 frequently reported plant essential oil components using a large retention index database. Retention data are presented for three types of commonly used stationary phases: dimethyl silicone (nonpolar), dimethyl sili- cone with 5% phenyl groups (slightly polar), and polyethylene glycol (polar) stationary phases. The evaluations are based on the treatment of multiple measurements with the number of data records ranging from about 5 to 800 per compound. Data analysis was limited to temperature programmed conditions. The data reported include the average and median values of retention index with standard deviations and confidence intervals. VC 2011 by the U.S. Secretary of Commerce on behalf of the United States. All rights reserved. [doi:10.1063/1.3653552] Key words: essential oils; gas chromatography; Kova´ts indices; linear indices; retention indices; identification; flavor; olfaction. CONTENTS 1. Introduction The practical applications of plant essential oils are very 1. Introduction................................ 1 diverse. They are used for the production of food, drugs, per- fumes, aromatherapy, and many other applications.1–4 The 2. Retention Indices ........................... 2 need for identification of essential oil components ranges 3. Retention Data Presentation and Discussion . 2 from product quality control to basic research. The identifi- 4. Summary.................................. 45 cation of unknown compounds remains a complex problem, in spite of great progress made in analytical techniques over 5.
    [Show full text]
  • Pharmacokinetic Interactions Between Herbal Medicines and Drugs: Their Mechanisms and Clinical Relevance
    life Review Pharmacokinetic Interactions between Herbal Medicines and Drugs: Their Mechanisms and Clinical Relevance Laura Rombolà 1 , Damiana Scuteri 1,2 , Straface Marilisa 1, Chizuko Watanabe 3, Luigi Antonio Morrone 1, Giacinto Bagetta 1,2,* and Maria Tiziana Corasaniti 4 1 Preclinical and Translational Pharmacology, Department of Pharmacy, Health and Nutritional Sciences, Section of Preclinical and Translational Pharmacology, University of Calabria, 87036 Rende, Italy; [email protected] (L.R.); [email protected] (D.S.); [email protected] (S.M.); [email protected] (L.A.M.) 2 Pharmacotechnology Documentation and Transfer Unit, Preclinical and Translational Pharmacology, Department of Pharmacy, Health and Nutritional Sciences, University of Calabria, 87036 Rende, Italy 3 Department of Physiology and Anatomy, Tohoku Pharmaceutical University, 981-8558 Sendai, Japan; [email protected] 4 School of Hospital Pharmacy, University “Magna Graecia” of Catanzaro and Department of Health Sciences, University “Magna Graecia” of Catanzaro, 88100 Catanzaro, Italy; [email protected] * Correspondence: [email protected]; Tel.: +39-0984-493462 Received: 28 May 2020; Accepted: 30 June 2020; Published: 4 July 2020 Abstract: The therapeutic efficacy of a drug or its unexpected unwanted side effects may depend on the concurrent use of a medicinal plant. In particular, constituents in the medicinal plant extracts may influence drug bioavailability, metabolism and half-life, leading to drug toxicity or failure to obtain a therapeutic response. This narrative review focuses on clinical studies improving knowledge on the ability of selected herbal medicines to influence the pharmacokinetics of co-administered drugs. Moreover, in vitro studies are useful to anticipate potential herbal medicine-drug interactions.
    [Show full text]
  • Next-Generation Sequencing of Representational Difference Analysis
    Planta DOI 10.1007/s00425-017-2657-0 ORIGINAL ARTICLE Next-generation sequencing of representational difference analysis products for identification of genes involved in diosgenin biosynthesis in fenugreek (Trigonella foenum-graecum) 1 1 1 1 Joanna Ciura • Magdalena Szeliga • Michalina Grzesik • Mirosław Tyrka Received: 19 August 2016 / Accepted: 30 January 2017 Ó The Author(s) 2017. This article is published with open access at Springerlink.com Abstract Within the transcripts related to sterol and steroidal Main conclusion Representational difference analysis saponin biosynthesis, we discovered novel candidate of cDNA was performed and differential products were genes of diosgenin biosynthesis and validated their sequenced and annotated. Candidate genes involved in expression using quantitative RT-PCR analysis. Based on biosynthesis of diosgenin in fenugreek were identified. these findings, we supported the idea that diosgenin is Detailed mechanism of diosgenin synthesis was biosynthesized from cycloartenol via cholesterol. This is proposed. the first report on the next-generation sequencing of cDNA-RDA products. Analysis of the transcriptomes Fenugreek (Trigonella foenum-graecum L.) is a valuable enriched in low copy sequences contributed substantially medicinal and crop plant. It belongs to Fabaceae family to our understanding of the biochemical pathways of and has a unique potential to synthesize valuable steroidal steroid synthesis in fenugreek. saponins, e.g., diosgenin. Elicitation (methyl jasmonate) and precursor feeding (cholesterol and squalene) were Keywords Diosgenin Á Next-generation sequencing Á used to enhance the content of sterols and steroidal Phytosterols Á Representational difference analysis of sapogenins in in vitro grown plants for representational cDNA Á Steroidal saponins Á Transcriptome user-friendly difference analysis of cDNA (cDNA-RDA).
    [Show full text]
  • Coptis Japonica</Emphasis>
    Plant Cell Reports (1988) 7:1-4 Plant Cell Reports © Springer-Verlag 1988 Alternative final steps in berberine biosynthesis in Coptisjaponica cell cultures E. Galneder 1 M. Rueffer 1, G. Wanner 1, 2, M. Tabata 1, 3, and M. H. Zenk 1 1 Lehrstuhl tar Pharmazeutische Biologie der Universitfit Mfinchen, Karlstrasse 29, D-8000 Mt~nchen 2, Federal Republic of Germany 2 Botanisches Institut der Universitfit Miinchen, Menzinger Strasse 67, D-8000 Manchen 19, Federal Republic of Germany 3 Faculty of Pharmaceutical Sciences, Kyoto University, Kyoto 606, Japan Received October 30, 1987 - Communicated by K. Hahlbrock ABSTRACT oxidase (STOX) reported from our laboratory (Amann et al., 1984) in that the Coptis enzyme dehydrogenated In Coptis japonica cell cultures an alternative path- only (S)-canadine while other tetrahydroprotober- way has been discovered which leads from (S)-tetra- berines were reported to be inactive. In further hydrocolumbamine via (S)-canadine to berberine. The contrast to the STOX enzyme, their enzyme did not two enzymes involved have been partially purified. produce hydrogen peroxide but rather H20 as one of (S)-Tetrahydrocolumbamine is stereospecifically the reaction products. Our analysis of the Coptis transformed into (S)-canadine under formation of the system reported here led to the surprising result methylenedioxy bridge in ring A. This new enzyme was that the terminal two steps in the biosynthesis of named (S)-canad/ne synthase. (S)-Canadine in turn is berberine in 8erberis and Coptis are biochemically stereospecifically dehydrogenated to berberine by an completely different while similar at the cytological oxidase, (S)-canadine oxidase (COX), which was level.
    [Show full text]
  • Determination of Cytotoxic Activity of Sanguinaria Canadensis Extracts
    molecules Article Determination of Cytotoxic Activity of Sanguinaria canadensis Extracts against Human Melanoma Cells and Comparison of Their Cytotoxicity with Cytotoxicity of Some Anticancer Drugs Tomasz Tuzimski 1,* , Anna Petruczynik 2,* , Tomasz Plech 3 , Barbara Kapro ´n 4, Anna Makuch-Kocka 3 , Małgorzata Szultka-Mły ´nska 5 , Justyna Misiurek 2 and Bogusław Buszewski 5 1 Department of Physical Chemistry, Medical University of Lublin, Chod´zki4a, 20-093 Lublin, Poland 2 Department of Inorganic Chemistry, Medical University of Lublin, Chod´zki4a, 20-093 Lublin, Poland; [email protected] 3 Department of Pharmacology, Medical University of Lublin, Chod´zki4a, 20-093 Lublin, Poland; [email protected] (T.P.); [email protected] (A.M.-K.) 4 Department of Clinical Genetics, Medical University of Lublin, Radziwiłłowska 11, 20-080 Lublin, Poland; [email protected] 5 Department of Environmental Chemistry and Bioanalytics, Faculty of Chemistry, Nicolaus Copernicus University, Gagarina 7, 87-100 Torun, Poland; [email protected] (M.S.-M.); [email protected] (B.B.) * Correspondence: [email protected] (T.T.); [email protected] (A.P.) Abstract: Melanoma is an enormous global health burden, and should be effectively addressed with Citation: Tuzimski, T.; Petruczynik, A.; better therapeutic strategies. Therefore, new therapeutic agents are needed for the management of Plech, T.; Kapro´n,B.; Makuch-Kocka, this disease. The aim of this study was the investigation of cytotoxic activity of some isoquinoline A.; Szultka-Mły´nska,M.; Misiurek, J.; alkaloid standards and extracts obtained from Sanguinaria canadensis—collected before, during, Buszewski, B. Determination of and after flowering—against three different human melanoma cells (A375, G361, SK-MEL-3).
    [Show full text]
  • (12) United States Patent (10) Patent No.: US 6,441,206 B1 Mikkonen Et Al
    USOO64.41206B1 (12) United States Patent (10) Patent No.: US 6,441,206 B1 Mikkonen et al. (45) Date of Patent: Aug. 27, 2002 (54) USE OF ORGANIC ACID ESTERS IN GB 1298047 11/1972 DIETARY FAT GB 2288805 * 7/1995 JP 588.098 A 1/1983 (75) Inventors: Hannu Mikkonen, Rajamäki; Elina JP 9194345 A 7/1997 Heikkilä, Vantaa, Erkki Anttila, Algy o Rajamäki; Anneli Lindeman, Espoo, all WO A19806405 2/1998 of (FI) OTHER PUBLICATIONS (73) Assignee: Raisio Benecol Ltd., Raisio (FI) Miettinen et al., New Technologies for Healthy Foods, pp. * Y NotOtice: Subjubject to anyy disclaimer,disclai theh term off thisthi 71-83 (1997). patent is extended or adjusted under 35 Habib et al., Sci. Pharm. vol. 49, pp. 253–257 (1981). U.S.C. 154(b) by 0 days. Mukhina e al., STN International, vol. 88, No. 7, pp. 1429-1430 (1977). (21) Appl. No.: 09/508,295 Mukhina et al., STN International, vol. 67, No. 9, pp. 587-589 (1967). (22) PCT Filed: Sep. 9, 1998 Tuomisto et al., Farmakologia Ja Toksikologia, pp. 526-534 (86) PCT No.: PCT/FI98/00707 (1982). Ikeda et al., J. Nutr Sci. Vitaminol, vol. 35, pp. 361-369 S371 (c)(1), (1989). (2), (4) Date: May 12, 2000 Heinemann et al., Eur: J. Clin. Pharmacol., 40(Suppl 1), pp. S59–S63 (1991). (87) PCT Pub. No.: WO99/15546 Mattson et al., J. Nutr, vol. 107, pp. 1139-1146 (1977). PCT Pub. Date: Apr. 1, 1999 Herting et al., Fed. Proc., vol. 19, pp. 18, (1960). Takagi et al., J.
    [Show full text]
  • Review Article Small Molecules from Nature Targeting G-Protein Coupled Cannabinoid Receptors: Potential Leads for Drug Discovery and Development
    Hindawi Publishing Corporation Evidence-Based Complementary and Alternative Medicine Volume 2015, Article ID 238482, 26 pages http://dx.doi.org/10.1155/2015/238482 Review Article Small Molecules from Nature Targeting G-Protein Coupled Cannabinoid Receptors: Potential Leads for Drug Discovery and Development Charu Sharma,1 Bassem Sadek,2 Sameer N. Goyal,3 Satyesh Sinha,4 Mohammad Amjad Kamal,5,6 and Shreesh Ojha2 1 Department of Internal Medicine, College of Medicine and Health Sciences, United Arab Emirates University, P.O. Box 17666, Al Ain, Abu Dhabi, UAE 2Department of Pharmacology and Therapeutics, College of Medicine and Health Sciences, United Arab Emirates University, P.O. Box 17666, Al Ain, Abu Dhabi, UAE 3DepartmentofPharmacology,R.C.PatelInstituteofPharmaceuticalEducation&Research,Shirpur,Mahrastra425405,India 4Department of Internal Medicine, College of Medicine, Charles R. Drew University of Medicine and Science, Los Angeles, CA 90059, USA 5King Fahd Medical Research Center, King Abdulaziz University, Jeddah, Saudi Arabia 6Enzymoics, 7 Peterlee Place, Hebersham, NSW 2770, Australia Correspondence should be addressed to Shreesh Ojha; [email protected] Received 24 April 2015; Accepted 24 August 2015 Academic Editor: Ki-Wan Oh Copyright © 2015 Charu Sharma et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. The cannabinoid molecules are derived from Cannabis sativa plant which acts on the cannabinoid receptors types 1 and 2 (CB1 and CB2) which have been explored as potential therapeutic targets for drug discovery and development. Currently, there are 9 numerous cannabinoid based synthetic drugs used in clinical practice like the popular ones such as nabilone, dronabinol, and Δ - tetrahydrocannabinol mediates its action through CB1/CB2 receptors.
    [Show full text]
  • (12) United States Patent (10) Patent No.: US 8,927.241 B2 Ajikumar Et Al
    USOO8927241B2 (12) United States Patent (10) Patent No.: US 8,927.241 B2 Ajikumar et al. (45) Date of Patent: *Jan. 6, 2015 (54) MICROBIAL ENGINEERING FOR THE 2010/0297722 A1 11/2010 Anterola et al. PRODUCTION OF CHEMICAL AND 38: i h S. A. s3. Fi Sharks et al. PHARMACEUTICAL PRODUCTS FROM THE Jikumar et al. ISOPRENOID PATHWAY FOREIGN PATENT DOCUMENTS (75) Inventors: Parayil K. Ajikumar, Cambridge, MA WO WO97,385.71 A1 10, 1997 (US); Gregory Stephanopoulos, Int (US); Too Heng Phon, OTHER PUBLICATIONS 73) Assi : M h Insti fTechnol Broun et al., Catalytic plasticity of fatty acid modification enzymes (73) SS1gnees: C s t it's R nology, underlying chemical diversity of plant lipids. Science, 1998, vol. 282: ambridge, ; Nationa 1315-1317. liversity of Singapore, Singapore Chica et al., Semi-rational approaches to engineering enzyme activ (SG) ity: combining the benefits of directed evolution and rational design. (*) Notice: Subject to any disclaimer, the term of this Curr. Opi. Biotechnol.-- 200 5, vol. 16. 378RSRRSRA 384. sk atent is extended or adjusted under 35 Devos et al., Practical limits of function prediction. Proteins: Struc p S.C. 154(b) by 354 days ture, Function, and Genetics. 2000, vol. 41: 98-107. M YW- y yS. Kisselev L., Polypeptide release factors in prokaryotes and This patent is Subject to a terminal dis- eukaryotes: same function, different structure. Structure, 2002, vol. claimer. 10:8-9. Seffernicket al., Melamine deaminase and Atrazine chlorohydrolase: (21) Appl. No.: 13/249,388 98 percent identical but functionally different. J. Bacteriol., 2001, vol. 183 (8): 2405-2410.* (22) Filed: Sep.
    [Show full text]
  • Astonishing Diversity of Natural Peroxides As Potential Therapeutic Agents Valery M Dembitsky* Institute of Drug Discovery, P.O
    a ular nd G ec en l e o t i M c f M o l e Journal of Molecular and Genetic d a i n c r i n u e o Dembitsky, J Mol Genet Med 2015, 9:1 J Medicine ISSN: 1747-0862 DOI: 10.4172/1747-0862.1000163 Review Article Open Access Astonishing Diversity of Natural Peroxides as Potential Therapeutic Agents Valery M Dembitsky* Institute of Drug Discovery, P.O. Box 45289, Jerusalem 91451, Israel *Corresponding author: Dembitsky VM, Institute of Drug Discovery, P.O. Box 45289, Jerusalem 91451, Israel, Tel: +972 526 877 444, E-mail: [email protected] Received date: January 28, 2015, Accepted date: February 25, 2015, Published date: March 04, 2015 Copyright: © 2015 Dembitsky VM. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited. Abstract Peroxides are an interesting group among biological active natural compounds. These metabolites contain a peroxide group (-O-O-) in which each oxygen atom is bonded to the other oxygen and to another atom. β-Oxygen in hydroperoxide group is considered as more active. Present review describes research on more than 230 natural peroxides isolated from plants, algae, and fungi. Intensive searches for new classes of biologically active metabolites produced by terrestrial and marine origin have resulted in the discovery of dozens of compounds possessing high antimalarial, antibacterial, cytotoxic, and other pharmacological activities as an important source of leads for drug discovery.
    [Show full text]
  • Microgram Journal, Vol 3, Number 2
    MICROGRAM Laboratory Operations Division Office Of Science And Drug Abuse Prevention BUREAU OF NARCOTICS & DANGEROUS DRUGS / U.S. DEPARTMENT OF JUSTICE / WASHINGTION, D.C. 20537 Vol.III, No. 2 March-April, 1970 STP (4-Methyl-2,5-dimethoxyamphetamine) hydrochloride was found coating the inside of capsules sent to BNDDfrom Germany. The capsules were clear, hard gelatin, standard shape size No. o. Average weight was 114 milligrams. Each capsule had a white crystalline coating on inner surface of capsule body. Apparently a measu~ed amount of solution had been placedin the cap·sule body, after which it was rotated to spread the solution on the inner surface. The substance contained 8. 7 milli­ grams STP (DOM)HCl per ca·psule. · These were the first STP capsules of this type seen by our laboratory. A few years ago, capsules were ob­ tained in the U.S. similarly coated with LSD. STP (Free Base) on laboratory filter paper, also from Germany, was seen for the first time in our laboratory. The STP spots, containing approxi­ mately 8 miliigrams STP base each, were 5/8 to 3/4 inch in diameter. The paper was 1\ inches square. Phencyclidine (Free Base) was recently analyzed on parsley leaves. Called "Angel DUst, 11 the phencyclidine on two samples of leaves was 2.6% and 3.6%. Approximately thirty pounds of 94% pure powder was also analyzed. (For identification of phencyclidine base, see Microgram, II, 1, p.3 (Jan 1969). IMITATIONSof well-known drug products are examined frequently in our Special Testing and Research Laboratory. Many of these are well made preparations and closely resemble the imitated product.
    [Show full text]